Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A
KNSA
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.95B
Close$
$84.67
5.2% upsideKiniksa Pharmaceuticals International Plc. Target Price Details
Target Price by Analysts
5.2% upsideKiniksa Pharmaceuticals International Plc. Target Price Details$-4.53
105.6% downside
Current Fair Value
105.6% downsideOvervalued by 105.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.95 Billion |
|---|---|
| Enterprise Value | $5.80 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.8 |
| Beta | 0.09 |
| Outstanding Shares | 77,577,675 |
Return
| Return on Equity | 12.33% |
|---|---|
| Return on Assets | 9.00% |
| Return on Invested Capital | 14.36% |
Valuation & Multiples
| P/E Ratio | 72.97 |
|---|---|
| PEG | 171.22 |
| Price to Sales | 8.05 |
| Price to Book Ratio | 10.06 |
| Enterprise Value to Revenue | 6.9 |
| Enterprise Value to EBIT | 55.75 |
| Enterprise Value to Net Income | 71 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$226.33 M
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.39
Average shareholder expectationRevenue Estimate
$259.65 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.5733▲ 355.13% |
|---|---|
| Total Calls | 90,700▼ 91.50% |
| Total Puts | 324,100▲ 1279.15% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 65.01%▲ 3.82% |
|---|---|
| Total Invested | $3.04B▲ 39.34% |
| Investors Holding | 276▲ 42.00% |
ESG Score
No data